Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo

Neoplasia

Volumn 11, Issue 3, 2009, Pages 228-236

  Zhong, Cai ^a,b   Qiuyan, Chen ^a,c   Jun, Chen ^d   Yi, Lu ^a   Guozhi, Xiao ^a   Zhihao, Wu ^d   Qinghua, Zhou ^d   Jian, Zhang ^a,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Tianjin Chest Hospital   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e Pittsburgh VA Healthcate System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE METASTASIS; BRONCHUS MUCOSA; CANCER MORTALITY; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 62549155841     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.81282     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, and Thun MJ (2008). Cancer statistics, 2008. CA Cancer J Clin 58, 71-96
2. Yang L, Parkin DM, Li LD, Chen YD, and Bray F (2004). Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 90, 2157-2166.
3. Mulshine JL and Sullivan DC (2005). Clinical practice. Lung cancer screening. N Engl J Med 352, 2714-2720.
4. Keller ET, Dai J, Escara-Wilke J, Hall CL, Ignatoski K, Taichman RS, and Keller J (2007). New trends in the treatment of bone metastasis. J Cell Biochem 102,1095-1102.
5. Becker S, Quay J, Koren HS, and Haskill JS (1994). Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma exptession in human airway epithelium and bronchoalveolar macrophages. Am J Physiol 266, L278-L286.
6. Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziche M, Santoni A, Capogrossi MC, and Napolitano M (2003). Analysis of the role of chemokines in angiogenesis. J Immunol Methods 273, 83-101.
7. Tangirala RK, Murao K, and Quehenberger O (1997). Regulation of exptession of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines. J Biol Chem 272, 8050-8056.
8. Kuroda T, Kitadai Y, Tanaka S, Yang X, Mukaida N, Yoshihara M, and Chayama K (2005). Monocyte chemoatttactant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment. Clin Cancer Res 11, 7629-7636.
9. Salcedo R, Ponce ML, Young HA, Wassetman K, Ward JM, Kleinman HK, Oppenheim JJ, and Murphy WJ (2000). Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blooded96, 34-40.
10. Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, and Gtaves DT (1992). Exptession of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 89, 5371-5375.
11. Iyonaga K, Takeya M, Saita N, Sakamoto O, Yoshimura T, Ando M, and Takahashi K (1994). Monocyte chemoattractant protein-1 in idiopathic pulmo nary fibrosis and other interstitial lung diseases. Hum Pathol 25, 455-463.
12. Cat BD, Meloni F, Luisetti M, Semenzato G, Gialdtoni-Grassi G, and Walz A (1994). Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 149, 655-659.
13. Vande Broek I, Asosingh K, Vanderkerken K, Sttaetmans N, Van Camp B, and Van Riet I (2003). Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3. Br J Cancer 88, 855-862.
14. Janis K, Hoeltke J, Nazareth M, Fanti P, Poppenbetg K, and Aronica SM (2004). Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes. Am J Reprod Immunol 51, 22-31.
15. Lu Y, Cai Z, Galson DL, Xiao G, Liu Y, George DE, Melhem MF, Yao Z, and Zhang J (2006). Monocyte chemotactic ptotein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 66, 1311-1318.
16. Lebreeht A, Heller L, Tempfer C, and Koelbl H (2001). Serum cytokine concentrations in patients with cervical cancer: interleukin-4, interferon-gamma, and monocyte chemoattractant protein-1. Gynecol Oncol 83, 170-171.
17. Heflet L, Tempfer C, Heinze G, Mayerhofer K, Breitenecker G, Leodolter S, Reinthaller A, and Kainz C (1999). Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients. Br J Cancer 81, 855-859.
18. Lu Y, Xiao G, Galson DL, Nishio Y, Mizokami A, Keller ET, Yao Z, and Zhang J (2007). PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro. Int J Cancer 121, 724-733.
19. Lu Y, Cai Z, Xiao G, Keller ET, Mizokami A, Yao Z, Roodman GD, and Zhang J (2007). Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res 67, 3646-3653.
20. Lu Y, Cai Z, Xiao G, Liu Y, Keller ET, Yao Z, and Zhang J (2007). CCR2 expression correlates with prostate cancer progression.JCellBiochem 101, 676-685.
21. LobergRD, Day LL, Harwood J, Ying C, St John LN, Giles R, Neeley CK, and Pienta KJ (2006). CCL2 is a potent regulatot of prostate cancet cell migration and proliferation. Neoplasia 8, 578-586.
22. Zhang J, Dai J, Qi Y, Lin DL, Smith P Strayhorn C, Mizokami A, Fu Z, Westman J, and Keller ET (2001). Osteoprotegerin inhibits prostate cancer-induced osteoclasto-genesis and prevents prostate tumor growth in the bone.JClin Invest 107,1235-1244.
23. Zhang J, Dai J, Yao Z, Lu Y, Dougall W, and Keller ET (2003). Soluble receptor activatot of nuclear factor kappaB Fc diminishes prostate cancer progression in bone. Cancer Res 63, 7883-7890.
24. Wang H, Yi T, Zheng Y, and He S (2007). Induction of monocyte chemoattractant protein-1 release from A549 cells by agonists of protease-activated receptor-1 and -2. Eur J Cell Biol 86, 233-242.
25. Smith DR, Polvetini PJ, Kunkel SL, Orringer MB, Whyte RI, Butdick MD, Wilke CA, and Strieter RM (1994). Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma J Exp Med 179, 1409-1415.
26. Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, and Topuz E (2006). Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancer. Cancer Invest 24, 492-496.
27. Orditura M, De Vita F, Catalano G, Infusino S, Lieto E, Martinelli E, Morgillo F, Castellano P Pignatelli C, and Galizia G (2002). Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosis. J Interferon Cytokine Res 22, 1129-1135.
28. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, and Strieter RM (1996). Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 97, 2792-2802.
29. Arenberg DA, Keane MR DiGiovine B, Kunkel SL, Strom SR, Burdick MD, Iannettoni MD, and Strieter RM (2000). Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother 49, 63-70.
30. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, and McCauley LK (2002). Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62, 1832-1837.
31. Dwinell MB, Eckmann L, Leopard JD, Varki NM, and KagnoffMF (1999). Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 117, 359-367.
32. Soejima Kand Rollins BJ (2001). A functional IFN-gamma-inducible protein-10/ CXCLlO-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.JImmunol 167, 6576-6582.
33. Scotton C, Milliken D, Wilson J, Raju S, and Balkwill F (2001). Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Br J Cancer 85, 891-897.
34. Shulby SA, Dolloff NG, Steatns ME, Meucci O, and Fatatis A (2004). CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res 64, 4693-4698.
35. Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, and Slawin KM (2001). Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancet progression and metastasis. Urology 58, 1008-1015.
36. Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R, and Dinney CP (2000). Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res 60, 2290-2299.
37. Reiland J, Furcht LT, and McCarthy JB (1999). CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate 41, 78-88.
38. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al. (2001). Involvement of chemokine re ceptors in breast cancer metastasis. Nature 410, 50-56.
39. FJwyer RM, Pottet-Beime SM, Harrington KA, Lowery AJ, Hennessy E, Murphy JM, Barry FP, O'Brien T, and Kerin MJ (2007). Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 13, 5020-5027.
40. Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya S, Skinner RA, Swain F, Ramani V, Mohammad KS, Wessner LL, et al. (2005). Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-KB ligand pathway. Cancer Res 65, 11001-11009